173 related articles for article (PubMed ID: 2436590)
1. Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome.
Swann AC; Koslow SH; Katz MM; Maas JW; Javaid J; Secunda SK; Robins E
Arch Gen Psychiatry; 1987 Apr; 44(4):345-54. PubMed ID: 2436590
[TBL] [Abstract][Full Text] [Related]
2. Studies of amine metabolites in depressed patients. Relationship to suicidal behavior.
Secunda SK; Cross CK; Koslow S; Katz MM; Kocsis JH; Maas JW
Ann N Y Acad Sci; 1986; 487():231-42. PubMed ID: 2436536
[No Abstract] [Full Text] [Related]
3. CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis.
Koslow SH; Maas JW; Bowden CL; Davis JM; Hanin I; Javaid J
Arch Gen Psychiatry; 1983 Sep; 40(9):999-1010. PubMed ID: 6193764
[TBL] [Abstract][Full Text] [Related]
4. CSF monoamine metabolites in mania.
Swann AC; Secunda S; Davis JM; Robins E; Hanin I; Koslow SH; Maas JW
Am J Psychiatry; 1983 Apr; 140(4):396-400. PubMed ID: 6188381
[TBL] [Abstract][Full Text] [Related]
5. The effect of lithium on urinary MHPG in unipolar and bipolar depressed patients.
Beckmann H; ST-Laurent J; Goodwin FK
Psychopharmacologia; 1975 Jun; 42(3):277-82. PubMed ID: 1161986
[TBL] [Abstract][Full Text] [Related]
6. Mania: gender, transmitter function, and response to treatment.
Swann AC; Petty F; Bowden CL; Dilsaver SC; Calabrese JR; Morris DD
Psychiatry Res; 1999 Oct; 88(1):55-61. PubMed ID: 10641586
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects.
Redmond DE; Katz MM; Maas JW; Swann A; Casper R; Davis JM
Arch Gen Psychiatry; 1986 Oct; 43(10):938-47. PubMed ID: 2428328
[TBL] [Abstract][Full Text] [Related]
8. The effect of lithium treatment on manic symptoms and levels of monoamine metabolites in cerebrospinal fluid of manic depressive patients.
Fyrö B; Petterson U; Sedvall G
Psychopharmacologia; 1975 Oct; 44(1):99-103. PubMed ID: 1105629
[TBL] [Abstract][Full Text] [Related]
9. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder.
Young LT; Warsh JJ; Kish SJ; Shannak K; Hornykeiwicz O
Biol Psychiatry; 1994 Jan; 35(2):121-7. PubMed ID: 7513191
[TBL] [Abstract][Full Text] [Related]
10. Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers.
Jönsson EG; Bah J; Melke J; Abou Jamra R; Schumacher J; Westberg L; Ivo R; Cichon S; Propping P; Nöthen MM; Eriksson E; Sedvall GC
BMC Psychiatry; 2004 Mar; 4():4. PubMed ID: 15102340
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.
Pickar D; Breier A; Hsiao JK; Doran AR; Wolkowitz OM; Pato CN; Konicki PE; Potter WZ
Arch Gen Psychiatry; 1990 Jul; 47(7):641-8. PubMed ID: 1694425
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid and plasma monoamines and their metabolites in euthymic bipolar patients.
Berrettini WH; Nurnberger JI; Scheinin M; Seppala T; Linnoila M; Narrow W; Simmons-Alling S; Gershon ES
Biol Psychiatry; 1985 Mar; 20(3):257-69. PubMed ID: 2579681
[TBL] [Abstract][Full Text] [Related]
13. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.
Bowden CL; Koslow SH; Hanin I; Maas JW; Davis JM; Robins E
Clin Pharmacol Ther; 1985 Mar; 37(3):316-24. PubMed ID: 2578912
[TBL] [Abstract][Full Text] [Related]
14. Effect of low-dose clorgyline on 24-hour urinary monoamine excretion in patients with rapidly cycling bipolar affective disorder.
Linnoila M; Karoum F; Potter WZ
Arch Gen Psychiatry; 1982 May; 39(5):513-6. PubMed ID: 6178382
[TBL] [Abstract][Full Text] [Related]
15. Lithium treatment of mania: clinical characteristics, specificity of symptom change, and outcome.
Swann AC; Secunda SK; Katz MM; Koslow SH; Maas JW; Chang S; Robins E
Psychiatry Res; 1986 Jun; 18(2):127-41. PubMed ID: 3725997
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical variables in delusional depression.
Lykouras E; Markianos M; Malliaras D; Stefanis C
Am J Psychiatry; 1988 Feb; 145(2):214-7. PubMed ID: 2449085
[TBL] [Abstract][Full Text] [Related]
17. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
[TBL] [Abstract][Full Text] [Related]
18. Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin.
Maas JW; Contreras SA; Seleshi E; Bowden CL
Arch Gen Psychiatry; 1988 Jun; 45(6):553-9. PubMed ID: 3377641
[TBL] [Abstract][Full Text] [Related]
19. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
[TBL] [Abstract][Full Text] [Related]
20. Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations.
Heinz A; Weingartner H; George D; Hommer D; Wolkowitz OM; Linnoila M
Psychiatry Res; 1999 Dec; 89(2):97-106. PubMed ID: 10646828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
